P104: Consolidation Therapy with Brentuximab Vedotin after Autologous Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Czech Republic.

• Jozef Michalka,
• Jana Marková,
• Ľubica Gahérová,
• Mária Maco,
• Vít Procházka,
• Jan Kořen,
• Alice Sýkorová,
• Pavla Štěpánková,
• Kateřina Steinerová,
• Lekaa Mohammad,
• Juraj Ďuraš,
• Barbora Velacková,
• Tomáš Doležal,
• Kateřina Benešová,
• Marie Lukášová,
• Andrea Janíková,
• Zdeněk. Král.,
• Heidi Móciková

Affiliations

Jozef Michalka

1 Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic

Jana Marková

2 Department of Hematology, University Hospital Kralovske Vinohrady and 3rd Faculty of Medicine, Charles University, Prague, Czech Republic

Ľubica Gahérová

2 Department of Hematology, University Hospital Kralovske Vinohrady and 3rd Faculty of Medicine, Charles University, Prague, Czech Republic

Mária Maco

2 Department of Hematology, University Hospital Kralovske Vinohrady and 3rd Faculty of Medicine, Charles University, Prague, Czech Republic

Vít Procházka

3 Department of Hematology, University Hospital Olomouc and Palacky University Olomouc, Czech Republic

Jan Kořen

4 st Department of Medicine, First Medical Faculty, Charles University and General University Hospital, Prague, Czech Republic

Alice Sýkorová

5 th Department of Internal medicine - Hematology, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic

Pavla Štěpánková

5 th Department of Internal medicine - Hematology, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic

Kateřina Steinerová

6 Department of Hematooncology, Charles University Hospital, Pilsen, Czech Republic

Lekaa Mohammad

6 Department of Hematooncology, Charles University Hospital, Pilsen, Czech Republic

Juraj Ďuraš

7 Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic

Barbora Velacková

8 Value Outcomes, Prague, Czech Republic

Tomáš Doležal

8 Value Outcomes, Prague, Czech Republic

Kateřina Benešová

4 st Department of Medicine, First Medical Faculty, Charles University and General University Hospital, Prague, Czech Republic

Marie Lukášová

3 Department of Hematology, University Hospital Olomouc and Palacky University Olomouc, Czech Republic

Andrea Janíková

1 Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic

Zdeněk. Král.

1 Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic

Heidi Móciková

2 Department of Hematology, University Hospital Kralovske Vinohrady and 3rd Faculty of Medicine, Charles University, Prague, Czech Republic